Literature DB >> 26939018

Industry is not the dark side, but an essential partner to make progress in reproductive health.

Thomas D'Hooghe1,2,3.   

Abstract

For the last 20 years, Thomas D'Hooghe has been coordinator of the Leuven University Fertility Center at Leuven University Hospitals, Belgium, one of the largest teaching hospitals in Europe. Since 1995, he has also been Professor of Reproductive Medicine and Biology at KU Leuven (University of Leuven) and Adjunct Professor at Yale University, USA. Since 1 October 2015, he has been the Vice President and Head of Global Medical Affairs Fertility at Merck's headquarters in Darmstadt, Germany. He has published nearly 300 papers in internationally peer-reviewed journals and has contributed to reproductive health serving major international organizations such as the WHO, the European Society of Human Reproduction and Embryology, the Society of Reproductive Investigation and the World Endometriosis Research Foundation.

Entities:  

Keywords:  academia; assisted reproduction; endometriosis; industry; pharma; public health; reproductive medicine; research; university; women's health

Mesh:

Year:  2016        PMID: 26939018      PMCID: PMC5375047          DOI: 10.2217/whe.15.106

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  50 in total

1.  Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

Authors:  Pamela J Goodwin; Marguerite Ennis; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Sara K Taylor; Nicky Hood
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

2.  Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study.

Authors:  Sophie Sell Hellmann; Lau Caspar Thygesen; Janne Schurmann Tolstrup; Morten Grønbaek
Journal:  Eur J Cancer Prev       Date:  2010-09       Impact factor: 2.497

3.  Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study.

Authors:  Shannon M Conroy; Gertraud Maskarinec; Lynne R Wilkens; Kami K White; Brian E Henderson; Laurence N Kolonel
Journal:  Breast Cancer Res Treat       Date:  2011-04-16       Impact factor: 4.872

4.  Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial.

Authors:  Rajendra Badwe; Rohini Hawaldar; Vani Parmar; Mandar Nadkarni; Tanuja Shet; Sangeeta Desai; Sudeep Gupta; Rakesh Jalali; Vaibhav Vanmali; Rajesh Dikshit; Indraneel Mittra
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

5.  The prognostic significance of lymphovascular invasion in invasive breast carcinoma.

Authors:  Emad A Rakha; Stewart Martin; Andrew H S Lee; David Morgan; Paul D P Pharoah; Zsolt Hodi; Douglas Macmillan; Ian O Ellis
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

6.  Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line.

Authors:  Stefania Catalano; Stefania Marsico; Cinzia Giordano; Loredana Mauro; Pietro Rizza; Maria Luisa Panno; Sebastiano Andò
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

7.  Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis.

Authors:  LaTonia Taliaferro-Smith; Arumugam Nagalingam; Brandi Brandon Knight; Elaine Oberlick; Neeraj K Saxena; Dipali Sharma
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

8.  Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women.

Authors:  Jennifer M Petrelli; Eugenia E Calle; Carmen Rodriguez; Michael J Thun
Journal:  Cancer Causes Control       Date:  2002-05       Impact factor: 2.506

9.  Adiposity and sex hormones in postmenopausal breast cancer survivors.

Authors:  Anne McTiernan; Kumar B Rajan; Shelley S Tworoger; Melinda Irwin; Leslie Bernstein; Richard Baumgartner; Frank Gilliland; Frank Z Stanczyk; Yutaka Yasui; Rachel Ballard-Barbash
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

10.  Serum progesterone and prognosis in operable breast cancer.

Authors:  P E Mohr; D Y Wang; W M Gregory; M A Richards; I S Fentiman
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

View more
  1 in total

1.  Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.

Authors:  Thomas D'Hooghe
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.